Shuanzeng Wei
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 17
- Sarcoma Diagnosis and Treatment 6
-
- Cancer Genomics and Diagnostics 9
- Co-authors
- Jun Hui Luo (2 shared papers)Thomas A. Dunn (2 shared papers)William B. Isaacs (2 shared papers)Zubair Wahid Baloch (10 shared papers)Virginia A. LiVolsi (9 shared papers)Misop Han (1 shared paper)Sumit Isharwal (1 shared paper)Rong Hu (1 shared paper)
- Journals
- Endocrine Pathology (8 papers)Acta Cytologica (3 papers)Cancers (3 papers)Modern Pathology (3 papers)Cancer Cytopathology (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Shuanzeng Wei
68 papers receiving 2.8k citations
Shuanzeng Wei's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 675
- Pulmonary and Respiratory Medicine 1.1k
- Endocrinology, Diabetes and Metabolism 348
- Oncology 487
- Molecular Biology 1.3k
Countries citing papers authored by Shuanzeng Wei
This map shows the geographic impact of Shuanzeng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuanzeng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuanzeng Wei more than expected).
Fields of papers citing papers by Shuanzeng Wei
This network shows the impact of papers produced by Shuanzeng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuanzeng Wei. The network helps show where Shuanzeng Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuanzeng Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer Hit paper breakdown → | 2008 | 901 |
| 2 | 2014 | 475 | |
| 3 | 2008 | 266 | |
| 4 | 2017 | 113 | |
| 5 | 2006 | 92 | |
| 6 | 2015 | 72 | |
| 7 | 2019 | 70 | |
| 8 | 2008 | 69 | |
| 9 | 2015 | 48 | |
| 10 | 2021 | 43 | |
| 11 | 2015 | 42 | |
| 12 | 2019 | 37 | |
| 13 | 2019 | 34 | |
| 14 | 2019 | 31 | |
| 15 | 2015 | 29 | |
| 16 | 2021 | 28 | |
| 17 | 2022 | 25 | |
| 18 | 2006 | 24 | |
| 19 | 2016 | 24 | |
| 20 | 2022 | 23 |
About Shuanzeng Wei
Shuanzeng Wei is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Endocrinology, Diabetes and Metabolism, Oncology and Surgery, having authored 76 papers that have together received 2.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (17 papers), Renal and related cancers (11 papers), Cancer Genomics and Diagnostics (9 papers), Thyroid Cancer Diagnosis and Treatment (7 papers), Salivary Gland Tumors Diagnosis and Treatment (7 papers), Sarcoma Diagnosis and Treatment (6 papers), BRCA gene mutations in cancer (6 papers) and Head and Neck Anomalies (4 papers). The work is most often cited by research in Cancer Research (675 citations), Pulmonary and Respiratory Medicine (1.1k citations), Endocrinology, Diabetes and Metabolism (348 citations), Oncology (487 citations) and Molecular Biology (1.3k citations). Shuanzeng Wei has collaborated with scholars based in United States, China and France. Frequent co-authors include Jun Hui Luo, Thomas A. Dunn, William B. Isaacs, Zubair Wahid Baloch, Virginia A. LiVolsi, Misop Han, Sumit Isharwal, Rong Hu, Elizabeth B. Humphreys and G. Steven Bova. Their work appears in journals such as Endocrine Pathology, Acta Cytologica, Cancers, Modern Pathology and Cancer Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.